Medline, Inc. (MDLN)
36.52
+0.52
(+1.43%)
USD |
NASDAQ |
Jun 10, 16:00
36.65
+0.12
(+0.34%)
After-Hours: 20:00
Medline Enterprise Value : 48.94B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 48.94B |
| June 08, 2026 | 47.07B |
| June 05, 2026 | 46.91B |
| June 04, 2026 | 47.62B |
| June 03, 2026 | 47.64B |
| June 02, 2026 | 46.55B |
| June 01, 2026 | 48.72B |
| May 29, 2026 | 49.41B |
| May 28, 2026 | 49.61B |
| May 27, 2026 | 48.78B |
| May 26, 2026 | 49.05B |
| May 22, 2026 | 49.77B |
| May 21, 2026 | 49.85B |
| May 20, 2026 | 49.13B |
| May 19, 2026 | 50.36B |
| May 18, 2026 | 48.93B |
| May 15, 2026 | 49.08B |
| May 14, 2026 | 51.37B |
| May 13, 2026 | 51.21B |
| May 12, 2026 | 51.07B |
| May 11, 2026 | 51.67B |
| May 08, 2026 | 51.89B |
| May 07, 2026 | 53.87B |
| May 06, 2026 | 54.00B |
| May 05, 2026 | 56.80B |
| Date | Value |
|---|---|
| May 04, 2026 | 55.84B |
| May 01, 2026 | 56.32B |
| April 30, 2026 | 56.08B |
| April 29, 2026 | 55.18B |
| April 28, 2026 | 55.89B |
| April 27, 2026 | 56.72B |
| April 24, 2026 | 56.33B |
| April 23, 2026 | 57.57B |
| April 22, 2026 | 58.36B |
| April 21, 2026 | 58.65B |
| April 20, 2026 | 59.29B |
| April 17, 2026 | 58.76B |
| April 16, 2026 | 58.17B |
| April 15, 2026 | 59.01B |
| April 14, 2026 | 58.79B |
| April 13, 2026 | 58.41B |
| April 10, 2026 | 57.05B |
| April 09, 2026 | 57.13B |
| April 08, 2026 | 55.99B |
| April 07, 2026 | 54.96B |
| April 06, 2026 | 55.60B |
| April 02, 2026 | 55.94B |
| April 01, 2026 | 55.70B |
| March 31, 2026 | 56.12B |
| March 30, 2026 | 55.68B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 186.33B |
| Baxter International, Inc. | 17.99B |
| Boston Scientific Corp. | 82.51B |
| Globus Medical, Inc. | 10.68B |
| Penumbra, Inc. | 12.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 239.00M |
| Revenue (Quarterly) | 7.352B |
| Total Expenses (Quarterly) | 7.223B |
| EPS Diluted (Quarterly) | 0.1525 |
| Gross Profit Margin (Quarterly) | 22.65% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | 3.27% |
| Operating Earnings Yield | 7.23% |
| Normalized Earnings Yield | 3.651 |